Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock ...

Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Thermo Fisher Scientific's third-quarter profit declined and revenue ... The company's largest division, Laboratory Products ...

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

Shares of Thermo Fisher Scientific Inc. TMO inched 0.96% higher to $560.79 Tuesday, on what proved to be an all-around great ...

Thermo Fisher Scientific's Q3 revenue of $10.59 billion missed expectations. Adjusted EPS beat estimates but dropped ...

Thermo Fisher Scientific Inc. has notified the state that it plans to lay off employees at two Massachusetts sites and close a third entirely.

Laboratory Products and Services: I project the segment will grow by 9%, in line with historical trends. As such, I calculate Thermo Fisher Scientific’s revenue will grow by 9% organically.

Thermo Fisher Scientific TMO is preparing to release ... analytical technologies (17% of sales); specialty diagnostic products (10%); life science solutions (23%); and lab products and services ...

Seer also announced a co-marketing and sales agreement with Thermo Fisher Scientific to jointly promote Proteograph alongside ...

The European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 ...